245 Summer Street,
Boston , MA, 02210
Boston , MA, 02210
Summary
The fund seeks capital appreciation by investing in companies outside the United States.
The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.
Next, the research team Invests in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and d More
Link
Directors
May 12, 2023- OSCAR MUNOZ
- ROBERT A LAWRENCE
- THOMAS A KENNEDY
- BETTINA DOULTON
- VICKI L FULLER
- THOMAS P BOSTICK
- PATRICIA L KAMPLING
- DENNIS J DIRKS
- DONALD F DONAHUE
- MICHAEL E WILEY
- SUSAN TOMASKY
- DAVID M THOMAS
Chief Compliance Officer
- JASON POGORELEC
Fund Manager(s)
Price
- 52-Week High/Low
- $31.58 - $24.48
- Turnover
- 42%
- Expense Ratio
- 0.70%
Company Name |
Holding |
| ELI LILLY and CO | 23.75 % |
| NOVO-NORDISK AS | 14.68 % |
| ASTRAZENECA PLC | 9.04 % |
| GSK PLC | 4.73 % |
| MERCK and CO INC | 4.73 % |
| UCB SA | 4.51 % |
| MODERNA INC | 3.38 % |
| GILEAD SCIENCES INC | 2.64 % |
| ROYALTY PHARMA PLC | 2.21 % |
| SAREPTA THERAPEUTICS INC | 2.15 % |
| More | 2.15 % |
Documents
Performance
YTD
-
3 Year
19.79%
5 Year
12.27%
Best
41.39%
2013
Worst
-23.37%
2002
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | - | 18.5% | -0.3% | -0.1% | -6.7% | -10% | 11% | 2.6% | 6.8% | -11.6% |
| Q2 | - | -1.7% | 2.9% | -3.4% | 18.4% | 12.8% | -1.4% | 3.2% | 5.1% | 4.5% |
| Q3 | - | - | -1.9% | -6% | -10.5% | -6.3% | -1.1% | 13.1% | 0.8% | -0.3% |
| Q4 | - | - | 4% | 5.9% | 3.7% | 3.3% | 10.7% | -9.1% | -3.6% | -9% |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | 5.2% | 8.5% | 3.8% | -2.9% | - | - | - | - | - | - | - | - |
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 15% | 4% | -4% | 0% | 2% | 21% | 6% | 11% | -16% |
Alpha
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| FPHAX | - | 15% | 4% | -4% | 0% | 2% | 21% | 6% | 11% | -16% |
| S&P 500 | - | - | - | -21% | 27% | 16% | 29% | -6% | 19% | 10% |
| Alpha | - | 15% | 4% | 17% | -27% | -15% | -8% | 12% | -9% | -26% |